$BioLine Rx(BLRX.US)$BioLineRx Has Drawn-down The Second Tranche Of $20M Under Its Previously Announced $40M Non-Dilutive Debt Financing Agreement With Funds And Accounts Managed By Blackrock
$BioLine Rx(BLRX.US)$BioLineRx Announces Notice of Allowance for U.S. Patent Covering Method of Manufacturing Motixafortide (BL-8040) Suitable for Large Scale Production, New Patent, When Issued, Will Be Valid Until December 2041
HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $21 Price Target: A Deep Dive into the Potential of $BLRX. BioLine Rx (NASDAQ: $BLRX), an Israeli biopharmaceutical development company, recently received a reiterated buy rating from the renowned investment bank, HC Wainwright & Co. The financial institution has maintained a price target of $21 for BioLine Rx, indicating a positive outlook for the company's futur...
$BioLine Rx(BLRX.US)$BioLineRx Entered Exclusive License Agreement To Motixafortide In Asia, Advisored By M.S.Q. Ventures; Provides $15M Upfront And Equity Investment Of $14.6M, Up To $50M In Development And Regulatory Milestones, Up To $200M In Commercial Milestones Benzinga· 3 mins ago
BioLine Rx股票討論區
BioLine Rx (NASDAQ: $BLRX), an Israeli biopharmaceutical development company, recently received a reiterated buy rating from the renowned investment bank, HC Wainwright & Co. The financial institution has maintained a price target of $21 for BioLine Rx, indicating a positive outlook for the company's futur...
presentation for (2) drugs news to be issued soon
Alpha.Scorpio 💪🏻🏆
Benzinga· 3 mins ago
$盛德財富(PWM.US)$ $Guardforce AI(GFAI.US)$ $Intuitive Machines(LUNR.US)$ $Amesite(AMST.US)$ $Tenax Therapeutics(TENX.US)$ $Buzzfeed(BZFD.US)$ $COMSovereign(COMS.US)$ $Minerva Surgical(UTRS.US)$ $Ault Alliance(AULT.US)$ $尚乘數科(HKD.US)$ $Micromobility.com(MCOM.US)$ $Cadrenal Therapeutics(CVKD.US)$ $Genius Group(GNS.US)$ $BBBYQ$ $Cosmos Health(COSM.US)$ $Panbela Therapeutics(PBLA.US)$ $APGN$ $Annexon(ANNX.US)$ $金太陽健康科技(GSUN.US)$ $Laser Photonics(LASE.US)$ $Cemtrex(CETX.US)$ $Troika Media(TRKA.US)$ $NextPlay Technologies(NXTP.US)$ $惠普森醫藥(CPHI.US)$ $Dianthus Therapeutics(DNTH.US)$ $Nuwellis(NUWE.US)$ $OpGen(OPGN.US)$ $Powerbridge Technologies(PBTS.US)$ $Healthcare Triangle(HCTI.US)$ $Digital Brands Group(DBGI.US)$ $Kintara Therapeutics(KTRA.US)$ $Ensysce Biosciences(ENSC.US)$ $休斯敦能源(HUSA.US)$ $AlTi Global(ALTI.US)$ $Zovio(ZVOI.US)$ $Agrify(AGFY.US)$ $Oblong(OBLG.US)$ $SOBR Safe(SOBR.US)$ $Nauticus Robotics(KITT.US)$ $Avenue Therapeutics(ATXI.US)$ $Blue Apron(APRN.US)$ $Bright Minds Biosciences Inc(DRUG.CA)$ $Applied DNA Sciences(APDN.US)$ $智富融資(MEGL.US)$ $Evolve Transition Infrastructure(SNMP.US)$ $Vivos Therapeutics(VVOS.US)$ $American Strategic Investment(NYC.US)$ $Icecure Medical(ICCM.US)$ $Applied Uv(AUVI.US)$ $ShiftPixy(PIXY.US)$ $Tempest Therapeutics(TPST.US)$ $特百惠(TUP.US)$ $Applied Uv(AUVI.US)$ $Yield10 Bioscience(YTEN.US)$ $Assure(IONM.US)$ $Versus Systems(VS.US)$ $The Alkaline Water(WTER.US)$ $TC BioPharm(TCBP.US)$ $Unicycive Therapeutics(UNCY.US)$ $Peraso(PRSO.US)$ $PARTS iD(ID.US)$ $富時新加坡海峽指數(.STI.SG)$ $旭日升科技(ASTI.US)$ $Abri SPAC I(ASPA.US)$ $Connexa Sports Technologies(CNXA.US)$ $Unique Fabricating(UFAB.US)$ $Aditxt(ADTX.US)$ $PainReform(PRFX.US)$ $Alpha Technology(ATGL.US)$ $Urgent.ly(ULY.US)$ $Bruush Oral Care(BRSH.US)$ $ReShape Lifesciences(RSLS.US)$ $Appreciate Holdings(SFR.US)$ ...
暫無評論